TrialArthritis & rheumatology (Hoboken, N.J.)2020

Efficacy and Safety of Upadacitinib Monotherapy in Methotrexate-Naive Patients With Moderately-to-Severely Active Rheumatoid Arthritis (SELECT-EARLY): A Multicenter, Multi-Country, Randomized, Double-Blind, Active Comparator-Controlled Trial.

Ronald van Vollenhoven et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.